|
Diabetes, Vol 36, Issue 10 1195-1202, Copyright © 1987 by American Diabetes Association
Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics
A Volund, KS Polonsky and RN Bergman
Department of Physiology and Biophysics, University of Southern California Medical School, Los Angeles 90033.
Prehepatic beta-cell insulin release can be calculated with C-peptide
measurements, but this requires independent determination of kinetics of
C-peptide disappearance from plasma. We introduce an approach by which a
prehepatic insulin release pattern is calculated from plasma insulin and
C-peptide, without separate C-peptide kinetic analysis. Human insulin and
C-peptide were infused intraportally into conscious dogs (n = 11) at
equimolar rates; endogenous insulin and C-peptide release were suppressed
with somatostatin (0.8 micrograms . kg-1 . min-1). Insulin and C-peptide
were infused at basal and equimolar rates (range 19-72 pmol/min in dogs),
and the infusions were slowly increased, in stepwise fashion, to a maximum
at 60 min (range 152-613 pmol/min) and subsequently renormalized at either
85 (n = 6) or 195 (n = 5) min. Plasma insulin and C-peptide measurements
were described simultaneously by a composite model of insulin and C-peptide
plasma kinetics, with the molar intraportal appearance rate due to the
infusion R(t) as an unknown input for both insulin and C-peptide
catabolism. The model assumes one-compartment disappearance kinetics for
both peptides. Fitting the model to the measured insulin and C-peptide
data, we were able to compute the insulin-appearance pattern accurately for
every experiment; calculated and actual secretion rates were highly
correlated (r = .93-.97) and had very similar temporal patterns. Also
calculated were the fractional disappearance rates for human insulin (t1/2
= 6.9 min) and C-peptide (t1/2 = 14 min) in the dog, as well as the
C-peptide distribution volume (12.3 +/- 0.5% body wt).(ABSTRACT TRUNCATED
AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Toffolo, M. Campioni, R. Basu, R. A. Rizza, and C. Cobelli
A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction
Am J Physiol Endocrinol Metab,
January 1, 2006;
290(1):
E169 - E176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Caumo and L. Luzi
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Am J Physiol Endocrinol Metab,
September 1, 2004;
287(3):
E371 - E385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tura, G. Pacini, A. Kautzky-Willer, B. Ludvik, R. Prager, and K. Thomaseth
Basal and dynamic proinsulin-insulin relationship to assess {beta}-cell function during OGTT in metabolic disorders
Am J Physiol Endocrinol Metab,
July 1, 2003;
285(1):
E155 - E162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Schmitz, S. Lund, P. H. Andersen, M. Jonler, and N. Porksen
Optimizing Insulin Secretagogue Therapy in Patients With Type 2 Diabetes: A randomized double-blind study with repaglinide
Diabetes Care,
February 1, 2002;
25(2):
342 - 346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Breda, G. Toffolo, K. S. Polonsky, and C. Cobelli
Insulin Release in Impaired Glucose Tolerance: Oral Minimal Model Predicts Normal Sensitivity to Glucose but Defective Response Times
Diabetes,
February 1, 2002;
51(90001):
S227 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tura, B. Ludvik, J. J. Nolan, G. Pacini, and K. Thomaseth
Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT
Am J Physiol Endocrinol Metab,
November 1, 2001;
281(5):
E966 - E974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Rosenfalck, S. Maghsoudi, S. Fisker, J. O. L. Jørgensen, J. S. Christiansen, J. Hilsted, A. Vølund, and S. Madsbad
The Effect of 30 Months of Low-Dose Replacement Therapy with Recombinant Human Growth Hormone (rhGH) on Insulin and C-Peptide Kinetics, Insulin Secretion, Insulin Sensitivity, Glucose Effectiveness, and Body Composition in GH-Deficient Adults
J. Clin. Endocrinol. Metab.,
November 1, 2000;
85(11):
4173 - 4181.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. Christiansen, L. L. Kjems, A. Volund, A. Tibell, C. Binder, and S. Madsbad
Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients
Am J Physiol Endocrinol Metab,
April 1, 1998;
274(4):
E716 - E725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Watanabe, G. M. Steil, and R. N. Bergman
Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion
Am J Physiol Endocrinol Metab,
January 1, 1998;
274(1):
E172 - E183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Christiansen, A. Tibell, Aa. Volund, J. J. Holst, K. Rasmussen, L. Schaffer, and S. Madsbad
Metabolism of Oral Glucose in Pancreas Transplant Recipients with Normal and Impaired Glucose Tolerance
J. Clin. Endocrinol. Metab.,
July 1, 1997;
82(7):
2299 - 2307.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1987 by the American Diabetes Association.
|
|
| |
|